[Pneumococcal serotypes in various diseases of children]

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|November 1, 1984
PubMed

Insights

This study identified 11 pneumococcal serotypes in children, with serotypes 3, 6, 9, and 19 being most common. Most strains remained sensitive to penicillin antibiotics.

Area of Science:

  • Microbiology
  • Pediatrics
  • Infectious Diseases

Background:

  • Pneumococcal infections pose a significant threat to children's health.
  • Understanding the serotype distribution and antibiotic susceptibility of pneumococci is crucial for effective disease management and prevention.

Purpose of the Study:

  • To serotype pneumococci isolated from children aged 0-11 years with various diseases.
  • To determine the etiological role of pneumococci in disease pathogenesis.
  • To assess the antibiotic susceptibility of isolated pneumococcal strains.

Main Methods:

  • Serotyping of pneumococcal isolates from clinical samples of 156 pediatric patients.
  • Quantitative inoculation methods to establish etiological significance.
  • Antibiotic susceptibility testing against penicillin, ampicillin, and benzylpenicillin.

Main Results:

  • Pneumococci were isolated from 43% (67/156) of patients.
  • Eleven distinct pneumococcal serotypes were identified.
  • Serotypes 3, 6, 9, and 19 were the most prevalent, accounting for 50% of isolates.
  • A correlation between pneumococcal serotype diversity and children's age was observed.
  • The majority of isolated strains exhibited sensitivity to penicillin, ampicillin, and benzylpenicillin.

Conclusions:

  • Specific pneumococcal serotypes are frequently associated with pediatric diseases.
  • Quantitative methods can elucidate the role of pneumococci in disease.
  • Age influences pneumococcal serotype distribution in children.
  • Pneumococci isolated in this study largely remained susceptible to common penicillin-based antibiotics.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...